Iracon2014

happy to share that there has been an unprecedented response to the abstract submission of 224 abstracts, almost double of last time.
Thank you guys.
looking forward to welcoming you at PGIMER Chandigarh.

has been an excellent response to ' Up against the wall- my most challenging case also'

Meet the IRACON International Faculty
Prof Peter Taylor.
Awarded a “Healthcare Champions Prize” in the Houses of Parliament in May 2008.
He is Norman Collisson Chair of Musculoskeletal Science at the University of Oxford, based within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences and leading clinical trials research.

Professor Taylor’s specialist clinical interests are in rheumatoid arthritis and early inflammatory arthritis.

He has been a principal investigator in numerous international clinical trials of biologic therapies including the earliest seminal trails of anti-TNF and anti-IL-6 receptor therapy.http://www.iracon2014.org/images/faculty_int/peter_c_taylor.jpg

www.iracon2014.org

Meet the faculty
Prof David Jayne,
Department of Medicine
University of Cambridge
Addenbooke's Hospital
Hills Road
Cambridge
Coordinator EUVAS Trials gp.
For the rheumatologists he needs no introduction but for those of you who don't know
Main/Senior author of major landmark vasculitis trials
namely
Cycazeram(NEJM 2003) AZA in maintenance of AAV
Anti tnf (J Am Soc Nephrol. 2004)
HCV Cryoglobulinemic vasculitis (Nephrol Dial Transplant 2005)
Mepex trial ( J Am Soc Nephrol. 2007) Plasmapheresis in AAV
RITUXIVAS(N Engl J Med. 2010) RTX in AA renal vasculitis
MMF vs AZA in remission maitainence in AAV (Arthritis Rheum. 2012)
.http://www.iracon2014.org/images/faculty_int/Dr_David_Jayne.jpg

www.iracon2014.org